medigraphic.com
ISSN 2594-1526 (Electronic)
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2020, Number 2

<< Back Next >>

Neumol Cir Torax 2020; 79 (2)

COVID-19: general recommendations and specifications for the patient with advanced lung cancer. Literature review

Sánchez-Ríos CP, Ramírez-Candelas MÁ, Menchaca-Dávila SA, Martínez-Barrera LOM, Rodríguez-Cid JR, Alatorre-Alexander JA

Language: Spanish
References: 25
Page: 101-109
PDF size: 330.26 Kb.


ABSTRACT

The outbreak of the new coronavirus disease 2019 (COVID-19) has become a threat to global health. We know that the risk of serious disease and death in COVID-19 cases increases with age and the presence of comorbid health conditions such as obesity, systemic arterial hypertension, diabetes mellitus, COPD, and immunosuppressed states such as cancer. Since the first case emerged in Wuhan, China in December 2019, huge research efforts have been made to understand the transmissibility mechanisms and potential therapeutic offerings that impact mortality rates. In this review, the potential challenges of the COVID-19 patient and lung cancer are raised.


REFERENCES

  1. Perlman S, Netland J. Coronaviruses pos-SARS: Update on replication and pathogenesis. Nat Rev Microbiol 2009;7(6):439-450. https://doi.org/10.1038/nrmicro2147.

  2. Chan JF, To KK, Tse H, Jin DY, Yuen KY. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol 2013;21(10):544-555. https://doi.org/10.1016/j.tim.2013.05.005.

  3. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol 2020;92(4):418-423. https://doi.org/10.1002/jmv.25681.

  4. Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020;9(1):221-236. https://doi.org/10.1080/22221751.2020.1719902.

  5. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020;382(13):1199-1207. https://doi.org/10.1056/nejmoa2001316.

  6. Bauch ChT, Lloyd-Smith JO, Coffee MP, Galvani AP. Dynamically modeling SARS and other newly emerging respiratory illnesses: Past, present, and future. Epidemiology 2005;16(6):791-801. https://doi.org/10.1097/01.ede.0000181633.80269.4c.

  7. Song W, Gui M, Wang X, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog 2018;14(8):e1007236. https://doi.org/10.1371/journal.ppat.1007236

  8. Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis. J Med Virol 2020;92(6):584-588. https://doi.org/10.1002/jmv.25719.

  9. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patient with pneumoniain China, 2019. N Engl J Med 2020;382(8):727-733. https://doi.org/10.1056/nejmoa2001017.

  10. Zhou P, Yang XL, Wang XG, et al . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(7798):270-273.https://doi.org/10.1038/s41586-020-2012-7.

  11. Huang Ch, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5.

  12. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72?314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-1242. https://doi.org/10.1001/jama.2020.2648.

  13. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, di Napoli R. Features, evaluation and treatment Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing; 2020.

  14. Yoon SH, Lee KH, Kim JY, et al. Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea. Korean J Radiol 2020;21(4):494-500. https://doi.org/10.3348/kjr.2020.0132.

  15. Xu YH, Dong JH, An WM, et al. Clinical and computed tomography imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. J Infect 2020;80(4):394-400. https://doi.org/10.1016/j.jinf.2020.02.017.

  16. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020;15(5):700-704. https://doi.org/10.1016/j.jtho.2020.02.010.

  17. Hui DS, Chow BK, Lo T, et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019;53(4):1802339. https://doi.org/10.1183/13993003.02339-2018.

  18. Gordon CJ, Tchesnokov EP, Feng JY, Porter DP, Götte M. The antiviral compound Remdesivir potently inhibits RNA-dependent RNA polymerase from middle east respiratory syndrome coronavirus. J Biol Chem 2020;295(15):4773-4779. https://doi.org/10.1074/jbc.ac120.013056.

  19. De Wit E, Feldmann F, Cronin J, et al. Prophylactic and therapeutic Remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci USA 2020;117(12):6771-6776. https://doi.org/10.1073/pnas.1922083117.

  20. Asociación Médica China, Rama de Oncología de la Asociación Médica China; Revista de la Asociación Médica China. Guía de Diagnóstico Clínico y Tratamiento del Cáncer de Pulmón de la Asociación Médica China (Edición 2018). Chinese J Oncology 2018;40(12):935-964. https://doi.org/10.3760/cma.j.issn.0253-3766.2018.12.012.

  21. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21(3):335-337. https://doi.org/10.1016/s1470-2045(20)30096-6.

  22. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. New England Journal of Medicine 2020. doi: 10.1056/NEJMoa2002032

  23. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-1062. https://doi.org/10.1016/s0140-6736(20)30566-3.

  24. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-481. Observational study. https://doi.org/10.1016/s2213-2600(20)30079-5.

  25. Zarogoulidis P, Kouliatsis G, Papanas N, et al. Long-term respiratory follow-up of H1N1 infection. Virol J 2011;8:319. https://doi.org/10.1186/1743-422x-8-319.




2020     |     www.medigraphic.com